|
|||||
|
|
Short communication: phase I clinical and gene modulatory evaluation of tamoxifen and IFN-alpha2b. |
|
| Authors: | Snehal G Thakkar David Peereboom Thomas Olencki Barbara Jacobs Paul Elson Lisa Rybicki Daniel J Lindner Ernest C Borden |
| Affiliation: | Center for Hematology and Oncology Molecular Therapeutics and Taussig Cancer Center, Cleveland Clinic Foundation, Cleveland, OH 44195, USA. |
| Abstract: | |
| Keywords: | |
